A Phase 2 Clinical Study of Pegerythropoietin Injection (RD01) for the Treatment of Anemia in Chronic Renal Failure Patients With Hemodialysis
Clinical trial NCT04231292 · UNKNOWN
Trial details
- NCT number
- NCT04231292
- Sponsor
- Shengzhen Sciprogen Bio-pharmaceutical Co. Ltd
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-03-01
- Primary completion
- 2020-06-30
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.